These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3694002

  • 1. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
    Imamura Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):934-41. PubMed ID: 3694002
    [No Abstract] [Full Text] [Related]

  • 2. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr 20; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y.
    Gan To Kagaku Ryoho; 1984 Dec 20; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [Abstract] [Full Text] [Related]

  • 4. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ.
    Cancer Treat Rev; 1985 Dec 20; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
    Takeyama H, Yano K, Kataoka T, Watanabe E, Kobayashi M, Ohno R.
    Rinsho Ketsueki; 1984 Dec 20; 25(12):1921-7. PubMed ID: 6442741
    [No Abstract] [Full Text] [Related]

  • 6. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Dec 20; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
    Wagstaff J, Loynds P, Scarffe JH.
    Cancer Treat Rep; 1985 May 20; 69(5):495-8. PubMed ID: 4005872
    [Abstract] [Full Text] [Related]

  • 8. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W, Gastl G, Tilg H, Troppmair J, Leiter E, Geissler D, Flener R, Huber C.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):172-81. PubMed ID: 3524022
    [Abstract] [Full Text] [Related]

  • 9. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
    Ohno R, Kimura K, Amaki I, Imamura Y, Masaoka T, Miyazaki T, Yoshida Y, Miura Y, Maekawa T, Oguro M.
    Cancer Treat Rep; 1985 Dec 30; 69(12):1433-5. PubMed ID: 4075317
    [Abstract] [Full Text] [Related]

  • 10. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y, Irie S, Inagaki M, Fukumoto M, Ueda I, Ohmoto E, Fujimoto S, Endo Y, Watanabe S, Lai M, Takahashi I, Kimura I, Ishii H, Sezaki T.
    Gan To Kagaku Ryoho; 1983 May 30; 10(5):1313-9. PubMed ID: 6575725
    [Abstract] [Full Text] [Related]

  • 11. [Effects of interferon on various malignancies].
    Taguchi T.
    Gan To Kagaku Ryoho; 1984 Feb 30; 11(2):194-204. PubMed ID: 6696457
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
    Ezaki K.
    Gan No Rinsho; 1983 May 30; 29(6):598-602. PubMed ID: 6308306
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
    Cox EB, Laszlo J, Krown S, Mintzer D, Sarna G.
    J Biol Response Mod; 1988 Jun 30; 7(3):318-25. PubMed ID: 3392554
    [Abstract] [Full Text] [Related]

  • 14. [Clinical efficacy of interferon-beta (MR-21) in renal cell carcinoma and cancer of the bladder].
    Niijima T.
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):928-33. PubMed ID: 3694001
    [No Abstract] [Full Text] [Related]

  • 15. Interferon-alpha: current status and future promise.
    Bonnem EM, Spiegel RJ.
    J Biol Response Mod; 1984 Dec 20; 3(6):580-98. PubMed ID: 6392483
    [No Abstract] [Full Text] [Related]

  • 16. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun 20; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 17. [Phase II study of interferon-beta (MR-21) in solid tumors. The Cooperative Study Group of MR-21 in Tumor].
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):942-7. PubMed ID: 3694003
    [No Abstract] [Full Text] [Related]

  • 18. [Interferons in cancerology. Focus in 1988].
    Boiron M.
    Pathol Biol (Paris); 1989 Feb 20; 37(2):92-3. PubMed ID: 2652080
    [No Abstract] [Full Text] [Related]

  • 19. Clinical uses for interferon in the treatment of cancer. A critical review.
    Ringenberg QS, Patterson WP.
    Mo Med; 1988 Jan 20; 85(1):21-6. PubMed ID: 3277031
    [No Abstract] [Full Text] [Related]

  • 20. Interferons and cancer therapy.
    Priestman TJ.
    J Pathol; 1983 Nov 20; 141(3):287-95. PubMed ID: 6363649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.